Search and analyze individual stocks with comprehensive metrics

Ambuja Cements Ltd

AMBUJACEMCement & Cement Products
552.15+0.00 (+0.00%)
As on 19 Jan 2026, 10:12 amMarket Open

Fundamental Score

...

Ambuja Cements Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

8.73%
Poor

Return on Capital Employed

10.50%
Excellent

Operating Profit Margin (5Y)

17.87%
Poor

Dividend Yield

0.37%

Valuation Metrics

Excellent

Price to Earnings

23.38x

Market Capitalization

1.34L (Cr)

Industry P/E

33.70x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

233.64%
Excellent

YoY Quarterly Sales Growth

21.48%
Poor

Sales Growth (5Y)

5.27%
Poor

EPS Growth (5Y)

9.79%
Excellent

Profit Growth (5Y)

14.63%

Financial Health

Excellent

Debt to Equity

0.02x
Excellent

Interest Coverage

29.40x
Poor

Free Cash Flow (5Y)

-1.88K (Cr)

Ownership Structure

Good

Promoter Holding

67.68%
Average

FII Holding

5.91%
Good

DII Holding

19.41%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.
67.68%
Promoter Holding
1.34L (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of AMBUJACEM across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Strong Operating Margins (17.87%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Attractive Valuation (P/E: 23.38 vs Industry: 33.70)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Robust Profit Growth (233.64%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (21.48%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Conservative Debt Levels (D/E: 0.02)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Interest Coverage (29.40x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Balanced Promoter Holding (67.68%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Strong Institutional Confidence (FII+DII: 25.32%)

Observation: Significant professional investor participation indicates quality recognition.

Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

2 factors identified

Below-Average Return on Equity (8.73%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Negative Free Cash Flow (₹-1880.66 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Loading Peer Comparison

Finding companies in the Cement & Cement Products sector...

Financial Statements

Comprehensive financial data for Ambuja Cements Ltd

About AMBUJACEM

Business Overview

Ambuja Cements Limited, together with its subsidiaries, manufactures, markets, and sells cement and related products to individual homebuilders, developers, infrastructure projects, masons and contractors, professionals, and architects and engineers in India. It offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Ahmedabad, India. Ambuja Cements Limited was formerly a subsidiary of Holderind Investments Ltd.

Company Details

Symbol:AMBUJACEM
Industry:Cement & Cement Products
Sector:Cement & Cement Products

Key Leadership

Mr. Vinod Mohanlal Bahety
CEO & Whole-Time Director
Mr. Manish Vinodchandra Mistry
Company Secretary & Compliance Officer
Mr. Ajay A. Kapur B.A., M.M.S.
MD & Director

AMBUJACEM Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)8.73%
Return on Capital Employed10.50%
Operating Profit Margin (5Y)17.87%
Debt to Equity Ratio0.02
Interest Coverage Ratio29.40

Growth & Valuation

Sales Growth (5Y)5.27%
Profit Growth (5Y)14.63%
EPS Growth (5Y)9.79%
YoY Quarterly Profit Growth233.64%
YoY Quarterly Sales Growth21.48%

Frequently Asked Questions

What is the current price of Ambuja Cements Ltd (AMBUJACEM)?

As of 19 Jan 2026, 10:12 am IST, Ambuja Cements Ltd (AMBUJACEM) is currently trading at ₹552.15. The stock has a market capitalization of ₹1.34L (Cr).

Is AMBUJACEM share price Overvalued or Undervalued?

AMBUJACEM is currently trading at a P/E ratio of 23.38x, compared to the industry average of 33.70x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Ambuja Cements Ltd share price?

Key factors influencing AMBUJACEM's price include its quarterly earnings growth (Sales Growth: 21.48%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Ambuja Cements Ltd a good stock for long-term investment?

Ambuja Cements Ltd shows a 5-year Profit Growth of 14.63% and an ROE of 8.73%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.02 before investing.

How does Ambuja Cements Ltd compare with its industry peers?

Ambuja Cements Ltd competes with major peers in the Cement & Cement Products. Investors should compare AMBUJACEM's P/E of 23.38x and ROE of 8.73% against the industry averages to determine its competitive standing.

What is the P/E ratio of AMBUJACEM and what does it mean?

AMBUJACEM has a P/E ratio of 23.38x compared to the industry average of 33.70x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹23 for every ₹1 of annual earnings.

How is AMBUJACEM performing according to Bull Run's analysis?

AMBUJACEM has a Bull Run fundamental score of 59.7/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does AMBUJACEM belong to?

AMBUJACEM operates in the Cement & Cement Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Ambuja Cements Ltd.

What is Return on Equity (ROE) and why is it important for AMBUJACEM?

AMBUJACEM has an ROE of 8.73%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Ambuja Cements Ltd generates profits from shareholders' equity.

How is AMBUJACEM's debt-to-equity ratio and what does it indicate?

AMBUJACEM has a debt-to-equity ratio of 0.02, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is AMBUJACEM's dividend yield and is it a good dividend stock?

AMBUJACEM offers a dividend yield of 0.37%, which means you receive ₹0.37 annual dividend for every ₹100 invested.

How has AMBUJACEM grown over the past 5 years?

AMBUJACEM has achieved 5-year growth rates of: Sales Growth 5.27%, Profit Growth 14.63%, and EPS Growth 9.79%.

What is the promoter holding in AMBUJACEM and why does it matter?

Promoters hold 67.68% of AMBUJACEM shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is AMBUJACEM's market capitalization category?

AMBUJACEM has a market capitalization of ₹134368 crores, placing it in the Large-cap category.

How volatile is AMBUJACEM stock?

AMBUJACEM has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for AMBUJACEM?

AMBUJACEM has a 52-week high of ₹N/A and low of ₹N/A.

What is AMBUJACEM's operating profit margin trend?

AMBUJACEM has a 5-year average Operating Profit Margin (OPM) of 17.87%, indicating the company's operational efficiency.

How is AMBUJACEM's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 21.48% and YoY Profit Growth of 233.64%.

What is the institutional holding pattern in AMBUJACEM?

AMBUJACEM has FII holding of 5.91% and DII holding of 19.41%. Significant institutional holding often suggests professional confidence in the stock.